NCT06899789View on ClinicalTrials.gov

Long-term Follow-up of Checkpoint Inhibitors-induced Ileo-colitis

RecruitingOBSERVATIONAL
Enrollment

250

Participants

Timeline

Start Date

July 29, 2022

Primary Completion Date

December 31, 2025

Study Completion Date

December 31, 2026

Conditions
Immune Checkpoint Inhibitors-induced ColitisAdvanced Melanoma Skin Cancer, Non-small Cell Lung Carcinoma, Kidney AdenocarcinomaIleo-colitisImmune Mediated-colitis
Trial Locations (1)

27100

RECRUITING

SC Medicina Generale 1, Fondazione IRCCS Policlinico san Matteo, Pavia

All Listed Sponsors
lead

Fondazione IRCCS Policlinico San Matteo di Pavia

OTHER